Amneal Pharmaceuticals, Inc. 4

Executive Vice President Andrew S. Boyer made a bona fide gift of 80,000 shares of Amneal Pharmaceuticals, Inc. Class A Common Stock to a family trust, leaving him with 193,646 shares owned directly.

On September 1, 2026, Executive Vice President Andrew S. Boyer of Amneal Pharmaceuticals, Inc. reported a transfer of 80,000 shares of Class A Common Stock as a gift to a trust for the benefit of certain family members, in which he does not serve as trustee. The transaction is coded as a bona fide gift (code G) and does not involve a sale for value, so no transaction price is reported. Following this gift, Boyer directly owned 193,646 shares of Amneal Class A Common Stock. This is a non‑discretionary, estate-planning type transfer rather than a market transaction, so it has limited direct signaling value regarding his outlook on the company.

Filing Facts

CIK

1723128

Ticker

AMRX

Form

4

Source Type

fda

Accession

0001628280-26-060179

Alert Tier

4